Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases
Disease area: Interstitial lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Zycinska, K. Wardyn, T. Zielonka, A. Bogaczewicz, E. Piotrowsa, M. Miskiewicz (Warsaw, Poland). Procalcitonin and systemic response to infection or active pulmonary Wegener‘s granulomatosis. Eur Respir J 2010; 36: Suppl. 54, 607

Member's Comments

No comment yet.

Related content which might interest you: The comparison of the manifestation of systemic inflammation in patients with minor forms of tuberculosis and pulmonary sarcoidosis Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009 Airway and systemic inflammation during Churg-Strauss syndrome natural course Source: Annual Congress 2012 - Monitoring of airway diseases: far from the airways Year: 2012 Non-infectious pulmonary complications in immunocompromised (IC) patients. Associated pulmonary and systemic inflammatory response Source: Eur Respir J 2004; 24: Suppl. 48, 241s Year: 2004 Pulmonary hypertension as the first manifestation in a patient with granulomatosis with polyangiitis Source: International Congress 2019 – Pulmonary vascular diseases? Year: 2019 c-ANCA-induced neutrophil-mediated lung injury: a model of acute Wegener's granulomatosis Source: Eur Respir J 2010; 36: 187-195 Year: 2010 A case of Wegener granulomatosis that mimics metastatic pulmonary tumor and progresses with eosinophilia Source: Annual Congress 2007 - Granulomatous lung diseases including sarcoidosis Year: 2007 Pulmonary and systemic inflammatory response in patients with pulmonary infections receiving long-term glucocorticoid therapy Source: Eur Respir J 2002; 20: Suppl. 38, 15s Year: 2002 Pulmonary manifestations of systemic vasculitis in childhood Source: Breathe, 16 (4) 200211; 10.1183/20734735.0211-2020 Year: 2020 Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis Source: Eur Respir J 2010; 36: 116-121 Year: 2010 Systemic inflammation and colonization in patients with clinically stable bronchiectasis Source: Eur Respir J 2007; 30: Suppl. 51, 528s Year: 2007 Predictive systemic biomarkers of pulmonary fibrosis after COVID-19 pneumonia Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 Evolution of systemic response in patients with pulmonary sarcoidosis of different course of the disease during anti-inflammatory treatment Source: Annual Congress 2009 - Sarcoidosis in review Year: 2009 Emergencies in interstitial and immunological lung disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=177 Year: 2006 Neutrophil chemotaxis in granulomatosis with polyangiitis (Wegener’s) and idiopathic pulmonary fibrosis Source: Eur Respir J 2011; 38: 1081-1088 Year: 2011 Community-aquired pneumonia: systemic and local inflammatory response in treatment failure Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008 Pulmonary arterial manifestation of systemic inflammation in patients with COPD Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Spontaneous resolutive pulmonary necrotizing granulomatosis Source: Virtual Congress 2020 – Rare lung diseases and lung manifestations of extrapulmonary diseases Year: 2020 Pulmonary involvement at presentation determines initial disease activity and permanent organ damage in ANCA-associated vasculitis Source: Annual Congress 2007 - Imaging of pulmonary vascularisation and illustrated overview of lung pathology Year: 2007 Systemic inflammation in COPD – a role for infection? Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases Year: 2008 Systemic autoimmunity and  pulmonary fibrosis Source: International Congress 2017 – GR3 Scientific Grand Round: Autoimmunity in chronic lung disease Year: 2017